NY-ESO-1 peptide vaccine
- Generic Name
- NY-ESO-1 peptide vaccine
- Drug Type
- Biotech
- Background
NY-ESO-1 peptide vaccine is an investigational cancer immunotherapy. It contains a peptide derived from the cancer-testis antigen (NY-ESO-1).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath